Difference between revisions of "NCCN guidelines"
Jump to navigation
Jump to search
| Line 3: | Line 3: | ||
'''Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any article published 5+ years ago to be for historical purposes, only.''' | '''Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any article published 5+ years ago to be for historical purposes, only.''' | ||
| − | =Miscellaneous= | + | ==Miscellaneous== |
[[Category:General reference pages]] | [[Category:General reference pages]] | ||
| Line 12: | Line 12: | ||
*'''2018:''' Bevers et al. [https://doi.org/10.6004/Jnccn.2018.0083 Breast Cancer Screening and Diagnosis, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology.] [https://pubmed.ncbi.nlm.nih.gov/30442736/ PubMed] | *'''2018:''' Bevers et al. [https://doi.org/10.6004/Jnccn.2018.0083 Breast Cancer Screening and Diagnosis, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology.] [https://pubmed.ncbi.nlm.nih.gov/30442736/ PubMed] | ||
| − | =Middle East and North Africa= | + | ==Middle East and North Africa== |
*'''2010:''' Abulkhair et al. [https://doi.org/10.6004/Jnccn.2010.0126 Modification and implementation of NCCN guidelines on breast cancer in the Middle East and North Africa region.] [https://pubmed.ncbi.nlm.nih.gov/20697133/ PubMed] | *'''2010:''' Abulkhair et al. [https://doi.org/10.6004/Jnccn.2010.0126 Modification and implementation of NCCN guidelines on breast cancer in the Middle East and North Africa region.] [https://pubmed.ncbi.nlm.nih.gov/20697133/ PubMed] | ||
*'''2010:''' Içli et al. [https://doi.org/10.6004/Jnccn.2010.0120 Modification and implementation of NCCN guidelines on colon cancer in the Middle East and North Africa region.] [https://pubmed.ncbi.nlm.nih.gov/20697127/ PubMed] | *'''2010:''' Içli et al. [https://doi.org/10.6004/Jnccn.2010.0120 Modification and implementation of NCCN guidelines on colon cancer in the Middle East and North Africa region.] [https://pubmed.ncbi.nlm.nih.gov/20697127/ PubMed] | ||
Revision as of 16:41, 30 November 2023
This page will be a gathering place for the National Comprehensive Cancer Network (NCCN) guidelines that do not clearly fit under a disease-specific page.
Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any article published 5+ years ago to be for historical purposes, only.
Miscellaneous
- 2003: Unknown et al. Breast Cancer Risk Reduction Clinical Practice Guidelines in Oncology. PubMed
- 2015: Bevers et al. Breast Cancer Risk Reduction, Version 2.2015. PubMed
- 2003: Unknown et al. Breast Cancer Screening and Diagnosis Clinical Practice Guidelines in Oncology. PubMed
- 2018: Bevers et al. Breast Cancer Screening and Diagnosis, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology. PubMed
Middle East and North Africa
- 2010: Abulkhair et al. Modification and implementation of NCCN guidelines on breast cancer in the Middle East and North Africa region. PubMed
- 2010: Içli et al. Modification and implementation of NCCN guidelines on colon cancer in the Middle East and North Africa region. PubMed
- 2010: Yusuf et al. Modification and implementation of NCCN guidelines on hepatobiliary cancers in the Middle East and North Africa region. PubMed
- 2010: Bazarbachi et al. Modification and implementation of NCCN guidelines on lymphomas in the Middle East and North Africa region. PubMed
- 2010: Jazieh et al. Modification and implementation of NCCN guidelines on non-small cell lung cancer in the Middle East and North Africa region. PubMed
- 2010: Shamieh et al. Modification and implementation of NCCN Guidelines on palliative care in the Middle East and North Africa region. PubMed
- 2010: Hassen et al. Modification and implementation of NCCN guidelines on prostate cancer in the Middle East and North Africa region. PubMed